In other words the chess pieces are slowly moving into better positions before the start of the assault. The assault being contract wins. Every customer endorsement makes it harder and harder to ignore. Painchek just needs to build the pressure until they crack. Exactly what happened with the NHS for Alcidion. The NHS are gonna look stupid for giving Alcidion a contract on one of their trusts and then not signing more. Same will be the case for Painchek, where customer referall will overwhelm the regulator and large customers.
PCK Price at posting:
8.3¢ Sentiment: Buy Disclosure: Held
